Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats
| Autor: | M. de Araujo Furtado, J.E. Schwartz, Mark C Moffett, Lore K. Wright, N.R. Kelley, A.R. Bourne, Caroline R. Schultz, Lucille A. Lumley, W.Z. Lumeh, Mark Schultz, Michael F. Stone |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Atropine
Male medicine.drug_class medicine.medical_treatment Soman Pyridinium Compounds Status epilepticus Cyclopentanes Caramiphen Pharmacology Toxicology Body Temperature Rats Sprague-Dawley Cellular and Molecular Neuroscience Epilepsy chemistry.chemical_compound Developmental Neuroscience Seizures Oximes Anticholinergic medicine Animals Maze Learning Diazepam Body Weight Brain medicine.disease Motor coordination Rats Anticonvulsant chemistry Anesthesia Anticonvulsants Drug Therapy Combination Cholinesterase Inhibitors medicine.symptom Psychology Cognition Disorders Locomotion medicine.drug |
| Zdroj: | Neurotoxicology and teratology. 44 |
| ISSN: | 1872-9738 |
| Popis: | The progression of epileptiform activity following soman (GD) exposure is characterized by a period of excessive cholinergic activity followed by excessive glutamatergic activity resulting in status epilepticus, which may lead to neuropathological damage and behavioral deficits. Caramiphen edisylate is an anticholinergic drug with antiglutamatergic properties, which conceptually may be a beneficial therapeutic approach to the treatment of nerve agent exposure. In the present study, rats were exposed to 1.2 LD50 GD or saline, treated with atropine sulfate (2mg/kg, im) and HI-6 (93.6mg/kg, im) 1min after GD exposure, and monitored for seizure activity. Rats were treated with diazepam (10mg/kg, sc) and caramiphen (0, 20 or 100mg/kg, im) 30min after seizure onset. Following GD exposure, performance was evaluated using a battery of behavioral tests to assess motor coordination and function, sensorimotor gating, and cognitive function. Caramiphen as adjunct to diazepam treatment attenuated GD-induced seizure activity, neuropathological damage, and cognitive deficits compared to diazepam alone, but did not attenuate the GD-induced sensorimotor gating impairment. These findings show that physiological, behavioral, and neuropathological effects of GD exposure can be attenuated by treatment with caramiphen as an adjunct to therapy, even if administration is delayed to 30min after seizure onset. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect